Heart failure market across 7MM to grow at 9.6% CAGR until 2032

One driver is the introduction of drugs targeting unmet needs.

The heart failure (HF) sector across the seven major markets is projected to reach $33.7b by 2032 at a compound annual growth rate of 9.6%, said GlobalData.

Key drivers of expansion include developments in treatment strategies and the introduction of drugs targeting unmet needs.

Meanwhile, pharmaceutical companies are focusing on improving treatment safety, compliance, and developing novel drug classes.

Kajal Jaddoo, Senior Pharma Analyst at GlobalData, said that new entrants to the HF market are likely to succeed if they offer novel therapies that address unmet clinical needs or improve patient compliance.

7MM = US, France, Germany, Italy, Spain, UK, and Japan.